Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Substance-Related Disorders
- Sponsor
- University of Oviedo
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Physical activity tracker adherence
- Status
- Completed
- Last Updated
- 7 months ago
Overview
Brief Summary
The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activity and improve the emotional state of people receiving an in-patient treatment for alcohol use disorder
Investigators
Alba González-Roz, PhD
Professor, PhD
University of Oviedo
Eligibility Criteria
Inclusion Criteria
- •Being 18 years old or older.
- •Be undergoing inpatient treatment for alcohol use disorder.
Exclusion Criteria
- •Finishing the treatment before 4 weeks.
Outcomes
Primary Outcomes
Physical activity tracker adherence
Time Frame: Treatment duration (4 weeks)
Days (percentage) in which activity tracker was used (day-time and night-time use)
Physical activity tracker perceived utility
Time Frame: End-of-treatment (4 weeks)
Perceived utility with the physical activity tracker will be assessed using ad-hoc questions about the utility of the activity tracker to increase levels of physical activity, improve sleep quality, and reduce/abandon tobacco.
Physical activity levels
Time Frame: In-treatment (4 weeks), from enrollment to end-of treatment (4 weeks)
Physical activity (PA) is operationalized as steps per day, plants climbed per day, distance covered per day (kilometers), light physical activity (minutes per day), moderate physical activity (minutes per week), vigorous physical activity (minutes per week), and sedentary time (hours per day). These outcomes will be measured using an adapted version of the International Physical Activity Questionnaire (IPAQ) and Fitbit Versa 3®.
Depression symptoms
Time Frame: From enrollment to the end-of-treatment (4 weeks)
Depression symptoms will be measured using the Patient Health Questionnaire-9 (PHQ-9). This questionnaire ranges from 0 to 14. A higher punctuation means higher depression symptom levels.
Anxiety symptoms
Time Frame: From enrollment to the end-of-treatment (4 weeks)
Anxiety symptoms will be measured using Generalized Anxiety Disorder-7 (GAD-7). This questionnaire ranges from 0 to 21. Higher punctuation means higher anxiety levels symptoms.
Difficulties in emotion regulation
Time Frame: From enrollment to the end-of-treatment (4 weeks)
Emotion dysregulation is measured using the Difficulties in Emotion Regulation Scale (DERS). Emotional dysregulation of negative emotions is measured with the Difficulties in Emotion Regulation Scale (DERS). This scale ranges from 28 to 140 points. A higher score means more difficulties in emotion regulation.
Physical activity tracker acceptability
Time Frame: End-of-treatment (4 weeks)
Acceptability of the activity tracker is measured using the Participant Experience Questionnaire (PEQ). This scale ranges from 10 to 50 points. A higher score means higher acceptability.
Sleep quality
Time Frame: In-treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)
Sleep quality will be measured using both the Pittsburg Sleep Quality Index (PSQI) and the Fitbit Versa 3. PSQI ranges from 0 to 21 points. A higher score means lower sleep quality. In addition, Fitbit Versa 3 provides a sleep quality punctuation ranging from 0 to 100. A higher punctuation means better sleep quality.
Secondary Outcomes
- Tobacco use(In treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks))
- Delay discounting (impulsive decision making)(From enrollment to the end-of-treatment (4 weeks))